XML 141 R103.htm IDEA: XBRL DOCUMENT v3.22.4
Supplementary Financial Information - Statements of (Loss) Income (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Restricted Cash and Cash Equivalents Items [Line Items]      
Research, development and engineering expenses $ 304 $ 310 $ 311
Selling, administrative and general expenses 1,760 1,718 1,851
Total Costs and Expenses 7,435 7,513 6,770
COVID-19 Pandemic, Aid And Economic Stimulus Savings      
Restricted Cash and Cash Equivalents Items [Line Items]      
Cost of sales 0 0 1
Cost of services, maintenance and rentals 0 20 73
Research, development and engineering expenses 0 1 1
Selling, administrative and general expenses 0 13 32
Total Costs and Expenses $ 0 $ 34 $ 107